• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2021 Dec 24;S1201-9712(21)01252-2.
doi: 10.1016/j.ijid.2021.12.351. Online ahead of print.
Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand


Thanyarat Promlek[SUP] 1 [/SUP], Maytawan Thanunchai[SUP] 2 [/SUP], Uraporn Phumisantiphong[SUP] 2 [/SUP], Tonsan Hansirisathit[SUP] 3 [/SUP], Chayanit Phuttanu[SUP] 3 [/SUP], Sunisa Dongphooyao[SUP] 3 [/SUP], Wipawee Thongsopa[SUP] 3 [/SUP], Pornlada Nuchnoi[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, poses an ongoing global threat, particularly in low-immunization coverage regions. Thus, rapid, accurate, and easy-to-perform diagnostic methods are in urgent demand to halt the spread of the virus.
Objective: We aimed to validate the clinical performance of the FastProof™ 30 min-TTR SARS-CoV-2 reverse transcription loop-mediated isothermal amplification (RT-LAMP) method using leftover ribonucleic acid (RNA) samples extracted from 315 nasopharyngeal swabs. The sensitivity and specificity of RT-LAMP were determined in comparison with RT-PCR.
Result: Out of 315 nasopharyngeal swabs, viral RNA was detected in 154 (48.9%) samples by RT-PCR assay. Compared with RT-PCR, overall sensitivity and specificity of RT-LAMP were 81.82% (95% CI: 74.81-87.57) and 100% (95% CI: 97.73-100), respectively. A 100% positivity rate was achieved in samples with cycle threshold (Ct) <31 for RT-PCR targeting the ORF1ab gene. However, samples with Ct >31 accounted for false-negative results by RT-LAMP in 28 samples.
Conclusion: RT-LAMP reliably detected viral RNA with high sensitivity and specificity and has potential application for mass screening of patients with acute COVID-19 infection, when viral load is high.

Keywords: COVID-19; RT-PCR; Sensitivity; Specificity; colorimetric RT-LAMP.
 
Back
Top Bottom